Financials
- Market Capitalization 342.61 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
1.01
Rapporto prezzo/fatturato
0.81
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3126 | IPSC Century Therapeutics, Inc. - Common Stock | 2.05 USD | +0.99% | -3.76% | 0.00% | +318.37% | 371.20 M USD | ||
| 3170 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.32 USD | -1.45% | -4.66% | +9.73% | -40.80% | 350.91 M USD | ||
| 3189 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.35 USD | -0.63% | -3.79% | -1.09% | +11.21% | 342.43 M USD | ||
| 3194 | FHTX Foghorn Therapeutics Inc. - Common Stock | 5.74 USD | -4.33% | -16.81% | +26.15% | +40.69% | 340.87 M USD |